In 2025, pharmacy leaders are grappling with a billion-dollar question: how to deliver high-quality, patient-centered care amid financial strain, policy uncertainty, and rapid technological change.

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...

Advancements in structural nanomedicine aim to standardize nanomedicine formulations, improving treatment consistency and ...

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

AI model reveals the structural secrets of misfolded proteins. A new artificial intelligence (AI) tool has provided critical ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level.

Discover how AI tailors chemo doses using digital twins - read more for breakthrough insights in precision oncology. Learn more.

Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.